| Polio elimination in Nigeria: a review UN Nasir, AS Bandyopadhyay, F Montagnani, JE Akite, EB Mungu, ... Human vaccines & immunotherapeutics 12 (3), 658-663, 2016 | 44 | 2016 |
| Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose … F Micoli, O Rossi, V Conti, O Launay, AS Scire, MG Aruta, UN Nakakana, ... Frontiers in Immunology 12, 671325, 2021 | 31 | 2021 |
| Towards a Four-Component GMMA-Based Vaccine against Shigella F Micoli, UN Nakakana, F Berlanda Scorza Vaccines 10 (2), 328, 2022 | 26 | 2022 |
| Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country … MC Kapulu, U Nakakana, AS Scire, E Sarakinou, V Conti, O Rossi, ... Frontiers in Immunology 13, 971866, 2022 | 14 | 2022 |
| Effect of intrapartum azithromycin vs placebo on neonatal sepsis and death: a randomized clinical trial A Roca, B Camara, JD Bognini, UN Nakakana, AM Somé, N Beloum, ... Jama 329 (9), 716-724, 2023 | 13 | 2023 |
| A validation of the Malaria Atlas Project maps and development of a new map of malaria transmission in Sokoto, Nigeria: a cross-sectional study using geographic information systems UN Nakakana, IA Mohammed, BO Onankpa, RM Jega, NM Jiya Malaria Journal 19, 1-12, 2020 | 10 | 2020 |
| Outer membrane vesicle vaccine platforms F Micoli, R Adamo, U Nakakana BioDrugs 38 (1), 47-59, 2024 | 6 | 2024 |
| Pre-delivery administration of azithromycin to prevent neonatal sepsis and death: a phase iii double-blind randomized clinical trial (PregnAnZI-2 trial) B Camara, JD Bognini, UN Nakakana, AM Some, I Jagne, MC Tahita, ... International Journal of Clinical Trials 9 (1), 34-34, 2022 | 5 | 2022 |
| Towards a four-component GMMA-based vaccine against F Micoli, UN Nakakana, SF Berlanda Shigella, 2022 | 5 | 2022 |
| GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB … I De Ryck, E Sarakinou, U Nakakana, GL Cilio, A Ndiaye, V Vella, ... Infectious Diseases and Therapy 11 (2), 757-770, 2022 | 3 | 2022 |
| Management of transverse septum in a low resource setting: a case report R Adejumo, TS Akande, YK Aminu, U Nakakana PAMJ-Clinical Medicine 4 (104), 2020 | 3 | 2020 |
| Polio in Nigeria: A review of the situation and problems hindering its elimination UN Nasir, AS Bandhyopadhyay, F MONTAGNANI, JA Elaine, BM Etaluka, ... HUMAN VACCINES & IMMUNOTHERAPEUTICS, 0-00, 2015 | 2 | 2015 |
| Mass vaccination campaigns in Nigeria and sub Saharan Africa: a review of three vaccines UN Nakakana, JE Akite, BE Mungu, IV Uche, IM Ahmed IOSR J Dent Med Sci 14 (9), 2015 | 1 | 2015 |
| Descriptive analysis of measles cases seen in a tertiary health facility in Sokoto, Northwest Nigeria–implication of disease eradication M Yahaya, KA Umar, JF Bello, BA Gwandu, Y Tahir, IB Sule, JA Kolawole, ... health 5, 6, 0 | 1 | |
| Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes U Nakakana, A Serry-Bangura, BE Edem, P Tessitore, L Di Cesare, ... Drugs in R&D, 1-12, 2024 | | 2024 |
| Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine V Conti, O Rossi, KA Clarkson, F Mancini, UN Nakakana, E Sarakinou, ... npj Vaccines 9 (1), 56, 2024 | | 2024 |
| Age-dependent acquisition of IgG antibodies to Shigella serotypes—a retrospective analysis of seroprevalence in Kenyan children with implications for infant … MC Kapulu, E Muthumbi, E Otieno, O Rossi, P Ferruzzi, F Necchi, ... Frontiers in Immunology 15, 1340425, 2024 | | 2024 |
| Effect of Intrapartum Azithromycin Versus Placebo on Neonatal Sepsis and Death: A Randomized Clinical Trial A Roca, B Camara, JD Bognini, UN Nakakana, AM Somé, N Beloum, ... Obstetric Anesthesia Digest 43 (4), 195-196, 2023 | | 2023 |
| Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort B Hanumunthadu, N Kanji, N Owino, CF Da Silva, H Robinson, R White, ... BMJ open 13 (11), e072938, 2023 | | 2023 |
| Towards establishing correlates of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei Generalized Modules for … U Nakakana, V Conti, O Rossi, K Clarkson, F Mancini, E Sarakinou, ... | | 2023 |
